EHRA Premium Access

Exploration of novel anti-fibrillatory strategies - A joint PhD-MD effort

Event: EHRA 2019
Topic: Arrhythmias
Session type: New ESC Guidelines
Date: 18 March 2019
Time: 11:00 - 12:30

Congress Session

5 presentations in this session

Next generation drugs for atrial fibrillation in humans - Good new chemistry

Speaker: Professor D. Dobrev (Essen, DE)
Thumbnail

Molecular therapy for genetic arrhythmogenic diseases - A white coats' tandem

Speaker: Professor S. Priori (Pavia, IT)
Thumbnail

Biological shockless defibrillation - True translational challenges

Speaker: Professor D. Pijnappels (Leiden, NL)
Thumbnail

Low voltage electrotherapy for atrial arrhythmias - First-in-human

Speaker: Professor I. Efimov (Washington, DC, US)
Thumbnail

Panel discussion

Thumbnail

4 speakers from this session

Professor Dobromir Dobrev

University Hospital of Essen (Ruhr), Essen (Germany)
7 presentations
1 follower

Professor Silvia Giuliana Priori

University of Pavia, Pavia (Italy)
22 presentations
4 followers

Professor Daniel Antonie Pijnappels

Leiden University Medical Center, Leiden (Netherlands (The))
3 presentations
0 follower

Professor Igor Efimov

George Washington University School of Medicine and Health Sciences, Washington, DC (United States of America)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk